The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects
Reviews in Medical Virology · 2026-03 · 36 (2)
DOI: 10.1002/rmv.70129 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, online erschienen am 03.03.2026. Verfasst von Alltalents T Murahwa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Disease and Molecular Medicine/Division of Medical Virology, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms, Papillomavirus Vaccines, Human Papillomavirus Viruses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Human papillomavirus (HPV35) is globally associated with only 2% of invasive cervical cancers (ICC) but demonstrates a disproportionately higher prevalence in sub‐Saharan Africa, reaching up to 10% in previous reports. In this review, we provide updated data from multiple African countries, revealing high HPV35 prevalence rates in women with precancerous and ICC lesions. Among women with ICC, the highest prevalence of HPV35 was observed in Mozambique (30% and 19%), Kenya (26% and 22%), South Africa (17%), Burkina Faso (13.7%), Zimbabwe (11%), and Tanzania (11.2%). Similarly, in women with precancerous lesions (LSIL/HSIL/CIN1‐3), the highest rates were recorded in Tanzania (26%) and Botswana (23% and 20%). These findings highlight a significant and underappreciated burden of HPV35‐associated cervical disease in African populations, particularly among women with precancerous and invasive lesions. The findings call for an urgent re‐evaluation of current HPV vaccination strategies to consider the inclusion of HPV35, which could profoundly enhance the effectiveness of cervical cancer prevention programs in sub‐Saharan Africa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Infectious Disease and Molecular Medicine/Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
- School of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa.
- Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.
- Pathology Department, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
- Department of Laboratory Diagnostic and Investigative Science-Medical Microbiology Unit, University of Zimbabwe, Harare, Zimbabwe.
ORCID-Profile: Alltalents T Murahwa, Mathias Dzobo, Patricia Rantshabeng
Zitieren
APA
Murahwa, A. T., Dzobo, M., Mahenge, A., Rantshabeng, P., & Dube Mandishora, R. S. (2026). The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects. Reviews in Medical Virology, 36(2). https://doi.org/10.1002/rmv.70129
Vancouver
Murahwa AT, Dzobo M, Mahenge A, Rantshabeng P, Dube Mandishora RS. The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects. Reviews in Medical Virology. 2026;36(2). doi:10.1002/rmv.70129
BibTeX
@article{Murahwa2026,
author = {Murahwa, Alltalents T and Dzobo, Mathias and Mahenge, Anifrid and Rantshabeng, Patricia and Dube Mandishora, Racheal S},
title = {The Burden of HPV35 in African Cervical Pathologies: Prevalence, Contributing Factors, and Vaccine Prospects},
journal = {Reviews in Medical Virology},
year = {2026},
volume = {36},
number = {2},
doi = {10.1002/rmv.70129}
}
EUVIMED